United States · FDA National Drug Code directory
SULINDAC
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24658-770_cb28dfa2-28af-47a2-ab7f-1c65720d9496
- Product NDC
- 24658-770
- Form
- TABLET
- Composition / generic term
- SULINDAC
- Labeler
- PuraCap Laboratories LLC dba Blu Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161114
- Source listing expiry
- 20261231
Source-listed ingredients
- SULINDAC — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (24658-770-01) · 24658-770-01
- 500 TABLET in 1 BOTTLE (24658-770-05) · 24658-770-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →